Tricuspid Valve Disease clinical trials at University of California Health

• Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

  open to eligible people ages 18 years and up

  To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitation who have been determined to be at an intermediate or greater estimated risk of mortality with tricuspid valve surgery by the cardiac surgeon with concurrence by the local Heart Team

  at UCLA

Last updated: October 6, 2021